My Learning

Alex Chen · Director, Market Access, Acme Therapeutics. Assigned paths, live sessions, and certificates.

Continue learning

2

Assigned paths

2

In progress

11.5

Hours completed

1

Certificates

Continue where you left off

The next required item on an assigned path.

In progress

The Gross-to-Net Waterfall

PBM Economics & the Net Pricing Channel · Rebates, Spreads, and Net Price · 18 min

List price is a starting fiction. This is the sequence of concessions that produces the number a manufacturer actually keeps.

Resume lesson

Assigned to you

Required training from Learning & Development. Due dates are for the 2026 cohort.

  • In progress

    Due October 31, 2026

    PBM Economics & the Net Pricing Channel

    How pharmacy benefit managers take margin — rebates, spread, and the fees that never appear on a claim — and what that does to manufacturer net price.

    Assigned by Dana Ruiz, Learning & Development · 6.5 hr · 4 CE

    46% complete

    Continue path
  • In progress

    Due November 21, 2026

    340B, Contract Pharmacy, and Manufacturer Policy

    Covered-entity eligibility, contract-pharmacy economics, and the policy fights that decide whether a 340B claim still looks like a 340B claim.

    Assigned by Dana Ruiz, Learning & Development · 5 hr · 3 CE

    18% complete

    Continue path

Upcoming required webinar

Live attendance is part of the assigned path — the recording does not replace the session.

Live

PBM Industry Update 2026

October 10, 2026 · 1:00–2:00 p.m. ET · Adam J. Fein, Ph.D.

Market share, rebate economics, and the Net Pricing Drug Channel — the live session that sits on this assigned path.

View session